As proved now by several preliminary studies performed by prestigious organizations, use of mobile technology in clinical trials can improve efficiency of the clinical research industry. It offers several merits such as: Continuous acquisition of data,…
According to a 2016 industry survey by FierceBiotech, more pharmaceutical companies are currently planning or piloting the use of mHealth (using devices such as sensors or wearables), in their clinical trials, than actually conducting trials using…
Today we live in an era where we cannot underscore enough, the importance of informed consent in research and treatment – for the safety of patients as well as the physicians treating them. Digital technology…
There is a growing realization for patient-centered healthcare system. The outcomes of a clinical intervention obtained by the patient i.e. patient-reported outcomes (PROs) may be of more importance in future than any other outcomes like clinical,…
According to National Institute of Health (NIH) a healthy volunteer is “someone with no known significant health problems who participates in research to test a new drug, device, or intervention”. They can also be called “Clinical Research Volunteers”….
We are excited to participate and present at the 7th annual DPharm: Disruptive Innovations to Advance Clinical Trials (#Dpharm2017) conference in Boston in the first week of September 2017. The first day of this conference, Sepetember…
The Centers for Disease Control and Prevention (CDC) describes mobile health (mHealth) as the practice of using mobile technologies to support public health and medicine. The ease of access and mobility provided by the use of…
